{"nct_id":"NCT01721772","title":"Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2013-01-18","start_date_type":"ACTUAL","primary_completion_date":"2014-06-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}